Skip to content

Clinical trials

Leukemia, Myeloid, Acute trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myeloid, Acute Country / region: Russia Clear all

51 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20102
20111
20133
20142
20154
20162
20176
20182
20198
20203
20214
20221
20231
20245
20255

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25
Recruiting10
Active, not recruiting8
Unknown status5
Terminated3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
St. Petersburg State Pavlov Medical University9
Federal Research Institute of Pediatric Hematology, Oncology and Immunology8
AbbVie5
Novartis Pharmaceuticals5
National Research Center for Hematology, Russia3
Celgene2
Ascentage Pharma Group Inc.1
Astellas Pharma Inc1
Astex Pharmaceuticals, Inc.1
Boehringer Ingelheim1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Acute51
Myelodysplastic Syndromes12
Precursor Cell Lymphoblastic Leukemia-Lymphoma12
Leukemia7
Graft vs Host Disease6
Leukemia, Biphenotypic, Acute6
Myeloproliferative Disorders5
Leukemia, Myelogenous, Chronic, BCR-ABL Positive4
Lymphoma, Non-Hodgkin3
Immune System Diseases2

Trials

Showing 51 to 51 of 51. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.